February 27, 2023
Workforce Development
• Career Development Award Program open to junior faculty members who are within the first five years of their first faculty appointment. This is a three-year $300,000 award.
• Health Equity and Inclusiveness Research Fellow Award Program for fellows who belong to underrepresented minorities in STEM who are interested in lung cancer research. This is a $100,000 two-year award.
• Health Equity and Inclusiveness Junior Investigator Research Award Program for physician-scientists (MDs, MD-PhDs, or equivalent) interested in conducting lung cancer clinical research. This is a $200,000 two-year award.
• VA Research Scholar Award Program to support investigators interested in lung cancer research within the US Department of Veterans Affairs. This is a $100,000 two-year award.
• ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant: This RFA is in partnership with the American Society for Radiation Oncology and will foster and develop the research careers of residents and fellows interested in radiation oncology-related basic, translational, and/or clinical research to benefit patients with lung cancer. This is a $25,000 one-year award. This award was established to advance the field of radiation oncology, given that at least 60% of patients with lung cancer will require some form of radiation therapy during the course of their disease.
Translational Research Awards (investigators at any stage of their career)
• Early Detection Award Program: This program supports translational research projects directed at new approaches to improve clinical methods for the detection and diagnosis of primary tumors. This is a two- or three-year $600,000 award.
• EGFR Resisters/LUNGevity Research Award Program for EGFR-Positive Lung Cancer, funds high-impact research that seeks to transform the future for patients diagnosed with EGFR-positive lung cancer. This is a $200,000 two-year award. The program is open to both US and non-US applicants.
• The Rising Tide/LUNGevity Team Award Program to Target Mechanisms of Resistance will fund high-impact research that seeks to develop therapeutic strategies targeting shared mechanisms of resistance in oncogene-driven lung adenocarcinoma. This is a $1,500,000 three-year team award. The program is open to both US and non-US applicants.
Deadline: February 27th, 2023
